Search clinical trials for: Moxifloxacin (Avalox®)

Total 14500 results

AstraZeneca

Completed

Four-period Crossover Study to Assess the Effects of Single Oral Doses of ZD4054 (Zibotentan) (10mg and 30mg) on QTc Interval

Healthy

United Kingdom
Movetis

Completed

Thorough Corrected QT Interval (QTc) Study To Evaluate Possible Effects of Prucalopride on ECG Parameters

Constipation
Bayer

Completed

Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric Patients

Infections

United States
Nabriva Therapeutics AG

Completed

Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia (LEAP2)

Community Acquired Pneumonia

United States, Argentina, Brazil, Bulgaria, Chile, Georgia, Hungary, Korea, Republic of, Latvia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Serbia, South Africa, Spain, Taiwan, Ukraine
Allergan

Completed

A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant Organisms

Anti-biotic Resistance

United States, Canada
University of Ulm
CAPNETZ Stiftung

Terminated

Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia (PENCAP)

Community Acquired Pneumonia

Germany
Melinta Therapeutics, Inc.

Completed

Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia (SOLITAIRE-IV)

Community-acquired Bacterial Pneumonia

Spain, United States, Philippines, Taiwan, Canada, Germany, Poland, Russian Federation, Argentina, Bulgaria, South Africa, Slovenia, Serbia, Colombia, Hungary, Netherlands, Slovakia, Ukraine, Peru, Latvia, Guatemala, Romania, Chile, G... and more
FORUM Pharmaceuticals Inc
Quintiles, Inc.

Completed

Phase 1 Study to Assess the Effects of EVP-6124 on the QT/QTc Interval in Healthy Subjects (TQT)

Healthy Subjects | Cardiac Repolarization
Teva Branded Pharmaceutical Products R&D, Inc.
Cetero Research, San Antonio

Completed

A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm

Healthy

United States
Bayer

Completed

Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease

Anti-Infective Agents

Japan
Bayer

Completed

Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis

Lung Diseases | Bronchitis, Chronic

Italy, Spain, United States, Greece, Chile, Germany, France, Mexico, Argentina, Israel, South Africa, Ireland, Brazil, United Kingdom, Andorra
Bayer

Completed

SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe Acute Exacerbations of Chronic Bronchitis (AECB) (SYMPROVE III)

Chronic Bronchitis

Germany
Bayer

Completed

Moxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI)

Abscess, Intra-Abdominal | Secondary Peritonitis

China
Bayer

Completed

Influence of Moxifloxacin on QTc Interval in Healthy Subjects for Positive Control Validation

Electrocardiography | QTc Evaluation

Singapore, Australia, Germany, United Kingdom
Bayer

Completed

Treatment of Patients With Acute Sinusitis

Acute Bacterial Sinusitis

China, France, Germany, Indonesia, Malaysia, Saudi Arabia, Singapore, Philippines, Austria, Jordan, Lebanon, Romania, Bahrain, Egypt, United Arab Emirates, Kuwait, Netherlands, Pakistan, Yemen
Chiesi Farmaceutici S.p.A.

Completed

Evaluation of Possible Effects on the QTc Interval of CHF 4226 pMDI in Healthy Volunteers (CT14)

Chronic Obstructive Pulmonary Disease

United States
Shire

Completed

Guanfacine Immediate-release Electrocardiogram Results (QTc) Study

Healthy Volunteers

United States
Bayer

Completed

CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox® in Hospitalized Patients

Pneumonia

Croatia, France, Hungary, Jordan, Kazakhstan, Lebanon, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Romania, Russian Federation, Ukraine
Astellas Pharma Inc

Completed

A Study to Evaluate the Effect of Oral Mirabegron on the Heart in Healthy Males and Females

Healthy Subjects

United States
Bayer

Completed

Avelox in Complicated Skin and Skin Structure Infections (ARTOS)

Skin Diseases, Bacterial

Germany, Indonesia, Korea, Republic of, Saudi Arabia, Philippines, Taiwan, Austria, Bulgaria, Slovenia, Egypt, Greece, Pakistan
Bayer

Completed

VICTOR - Avelox® Intravenous (i.v.) in Acute Exacerbations of Chronic Bronchitis (VICTOR)

Chronic Bronchitis | Disease Exacerbation

China
Bayer

Completed

AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs

Bronchitis, Chronic

Slovakia, Kazakhstan, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Russian Federation, Ukraine, Bosnia and Herzegovina, Albania
River Pharma S.r.l.

Completed

Clinical Trial to Evaluate the Effects of a Nutraceutical in Patients Affected by Knee Osteoarthritis (SMILE)

Knee Osteoarthritis

Romania
GlaxoSmithKline
Shionogi

Completed

Study to Assess Cardiac Conduction of GSK1349572

Healthy Subjects

United States
Cara Therapeutics, Inc.

Completed

Study to Investigate the Effects of Single Intravenous Doses of Difelikefalin (CR845) on the QTc Interval in Healthy Subjects

Healthy

United States
Melinta Therapeutics, Inc.

Completed

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia (SOLITAIRE-ORAL)

Community-acquired Bacterial Pneumonia

Spain, United States, Hungary, Canada, Estonia, Russian Federation, Argentina, Bulgaria, Czech Republic, Dominican Republic, Ecuador, Germany, Latvia, Poland, Puerto Rico, Romania, South Africa
BeiGene

Completed

A Two-Part Phase 1 Study to Investigate the Safety and Tolerability of Supratherapeutic Dose of Zanubrutinib and Effect of Zanubrutinib on Cardiac Repolarization in Healthy Subjects

Healthy Volunteers

United States
AiCuris Anti-infective Cures AG

Completed

Thorough QT/QTc of Pritelivir in Healthy Subjects

HSV Infection

United Kingdom
Hoffmann-La Roche

Completed

Study to Investigate the Effect of Balovaptan on the QTC Interval in Healthy Subjects

Healthy Volunteers

United States
Purdue Pharma LP

Completed

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers

Healthy Volunteers

United States
Bayer

Completed

A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs (MERAK)

Infectious Diseases

Italy
Bayer

Completed

Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem

Infection

Belgium, France, Argentina, Spain, Germany, Israel, Romania, Bulgaria, Russian Federation, Lithuania, South Africa, Latvia, Greece, Estonia
Beijing Hospital

Unknown

Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors

Community-Acquired Pneumonia

China
Spero Therapeutics
Celerion

Completed

A Single-Dose, Randomized, Placebo- and Active-Control, Four-Way, Cross-Over Study for the Evaluation of the Effect of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) on the QT/QTc Intervals in Adult Healthy Subjects

TQT Study

United States
Melinta Therapeutics, Inc.

Completed

Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia (DEFINE-CABP)

Community Acquired Bacterial Pneumonia

United States, Argentina, Bulgaria, Colombia, Dominican Republic, Georgia, Germany, Hungary, Latvia, Peru, Poland, Romania, Russian Federation, Serbia, Slovenia, South Africa, Spain, Ukraine
Alexion Pharmaceuticals
Achillion, a wholly owned subsidiary of Alexion

Completed

A Study of the Cardiac Effects of Danicopan in Healthy Adults

Healthy

United States
Bayer

Completed

BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia

Pneumonia, Aspiration | Lung Abscess

Germany
Melinta Therapeutics, Inc.

Completed

A Study to Assess the Cardiac Safety of Oritavancin in Healthy Participants

Healthy

United States
Daiichi Sankyo, Inc.

Completed

The Effect of CS-3150 Exposure on Corrected QT (QTc) Interval Duration in Healthy Volunteers

Hypertension | Mineralocorticoid Receptor Antagonist

United States
Bayer

Completed

Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections) (DRAGON)

Infection, Intra-abdominal

China, Hong Kong, Indonesia, Korea, Republic of, Malaysia, Taiwan
Bayer

Completed

Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection (MOXIPEDIA)

Intraabdominal Infections

Greece, Peru, United States, Chile, Bulgaria, Canada, Russian Federation, Lithuania, Germany, Hungary, Latvia, Romania, Ukraine, Czechia, Argentina, Mexico
Boehringer Ingelheim

Completed

Effect of BI 1356 as Single Dose on the QT Interval in Healthy Female and Male Subjects

Healthy
Nabriva Therapeutics AG

Completed

Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia (LEAP)

Community Acquired Pneumonia

United States, Argentina, Bosnia and Herzegovina, Brazil, Bulgaria, Georgia, Hungary, Latvia, Netherlands, Peru, Philippines, Poland, Romania, Russian Federation, Serbia, South Africa, Thailand, Ukraine
Bristol-Myers Squibb

Completed

Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects

Alzheimer Disease

United States
Global Alliance for TB Drug Development

Completed

Shortening Treatment by Advancing Novel Drugs (STAND)

Tuberculosis, Pulmonary, Drug Sensitive | Tuberculosis, Pulmonary, Multi Drug-resistant

South Africa, Zambia, Georgia, Philippines, Kenya, Malaysia, Tanzania, Uganda
Bristol-Myers Squibb

Completed

Study to Determine the Effect of Efavirenz on the ECG QTcF Interval in Healthy Subjects

HIV/AIDS

United States
sigma-tau i.f.r. S.p.A.
Medicines for Malaria Venture

Completed

Safety Study on the Effect of Eurartesim™ on QT/QTc Interval Compared to Riamet in Healthy Volunteers

Malaria, Falciparum

France
Janssen Scientific Affairs, LLC
Bausch Health Americas, Inc.; Cipher Pharmaceuticals Inc.

Completed

Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants

Healthy

United States
Chelsea Therapeutics

Completed

Electrocardiographic (ECG) Safety Study of Droxidopa at Clinical and Supratherapeutic Dose

QTc Interval

United States
Astellas Pharma Inc

Completed

A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy Subjects

Healthy Subjects | Cardiac Repolarization

United States

Search clinical trials for: Moxifloxacin (Avalox®)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations